4//SEC Filing
Adamis Pharmaceuticals Corp 4
Accession 0001387131-16-004984
CIK 0000887247operating
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 2:57 PM ET
Size
5.5 KB
Accession
0001387131-16-004984
Insider Transaction Report
Form 4
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
- Award
Common Stock
2016-04-13+866,666→ 866,666 total
Footnotes (1)
- [F1]200,000 of these shares of common stock will be held in escrow until April 11, 2019 to satisfy the indemnification obligations of Mr. Glover under the Agreement and Plan of Merger, dated as of March 28, 2016 by and among Adamis Pharmaceuticals Corporation ("Adamis"), U.S. Compounding, Inc. ("USC"), and a wholly owned subsidiary of Adamis. In addition, 500,000 of these shares of common stock are subject to vesting under a milestone agreement entered into by Mr. Glover. Under the milestone agreement, one-third of these shares vest and are released to Mr. Glover annually over a period of three years from April 11, 2016 provided that Mr. Glover continues to be employed by USC or Adamis (with certain exceptions) as of the applicable vesting date.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000887247
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 2:57 PM ET
- Size
- 5.5 KB